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1. Introduction 
Prematurity is a condition associated with high mortality and overall survived rates are near 
77.5% (Stoll et al., 2010).Those who survived are at high risk of severe impairment (Bassler et 
al., 2009). Two percent of all live births are premature with less than 32 weeks of gestational 
age and 1.5% of them are very low birth weight (Mathews et al., 2011). The most common 
injury affecting brain of these children is periventricular leukomalacia (PVL) and 
intraventricular hemorrhage (IVH). PVL is the main cause of cognitive behavioural, motor 
and sensory impairments found in children born before 32 weeks of gestational age (Volpe, 
2003). IVH has a negative impact on the neurodevelopmental outcome and is due not only 
to the direct consequences of IVH but also associated lesions, such as posthemorrhagic 
hydrocephalus (PHH) and PVL. The knowledge, prevention, diagnosis and early treatment 
of these clinical conditions improve the prognosis and neurological outcomes.   
2. Brain injury in the premature infant 
2.1 Intraventricular hemorrhage  
In the late 1970s the incidence of IVH was near 50%. At the present time it is near 20 to 30%. 
The absolute number of infants with IVH remains significant due to increase survival rate of 
premature infants especially in very low birth weight, who are at high risk of IVH. Virtually 
all IVH in premature infants occurs within the first five days of life, with 50, 25 and 15 
percent on the first, second and third day respectively, and 10 percent on the fourth day or 
after. IVH progresses over three to five days in approximately 20 to 40 percent of cases 
(Volpe, 2008; Groenendaal et al., 2010). PHH, periventricular hemorrhagic infarction (PVHI), 
and PVL are the most important sequelae of IVH. The first occurs in approximately 25% of 
infants with IVH and usually it begins within one to three weeks after the brain bleeding 
(Murphy et al., 2002). PVHI pathogenesis is thought to result from infarction caused by 
venous obstruction after a germinal matrix IVH (Bassan, 2009; Volpe, 1998). The parietal and 
frontal cerebral areas are the most often involved (Bassan et al., 2006a). PVL is the mayor 
form of brain white matter in neonates especially in premature infants. There is a strong 
association between PVL and IVH and data suggest the IVH may exacerbate PDL (Bassan, 
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2009). The short term outcome is closely related to the severity of IVH (Kusters et al., 2009). 
The long term outcome of infants, who survive of IVH, worsens with increasing severity of 
IVH and decreasing gestational age (Sherlock et al., 2005; Luu et al., 2009).  
2.1.1 Risk factors and pathogenesis 
IVH originates from the fragile involuting vessels of subependymal germinal matrix, located 
in the caudothalamic groove. The pathogenesis of this in preterm infants has been 
demonstrated to be related to numerous risk factors which can be divided into 
intravascular, probably the most important and amenable to preventive efforts, vascular and 
extravascular factors (Table 1). Intravascular factors are ischemia and reperfusion, like in 
volume infusion after hypotension, fluctuating cerebral blood flow (CBF), like in mechanical 
ventilation, increase in CBF, like in hypertension, anemia and hipercarbia, increase in 
cerebral venous pressure and platelet dysfunction and coagulation disturbances. Vascular 
factors consider tenuous and involuting capillaries with large diameter lumen. 
Extravascular factors are deficient vascular support and excessive fibrinolytic activity 
(Perlman et al., 1983; Lou, 1988; Pryds et al., 1989). For developing PVHI the risk factors are 
low birth gestational age, low Apgar scores, early life acidosis, patent ductus arteriosus, 
pneumothorax, pulmonary hemorrhage and needed for significant respiratory or blood 
pressure support (Bassan et al., 2006b). PHH likely relates at least in part to impaired 
cerebral spinal fluid resorption or obstruction of the acueduct or the foramina of Luschka or 
Magendie by particulate clot (Larroche, 1972).  
 
Pathogenesis of IVH 
Intravascular 
factors 
Ischemia /reperfusion 
Fluctuating cerebral blood flow 
Increase in cerebral blood flow 
Increase in cerebral venous pressure 
Platelet dysfunction and coagulation disturbances 
Vascular 
factors 
Tenous, involuting capillaries with large diameter lumen 
Extravascular 
factors 
Deficient vascular support 
Excessive fibrinolytic activity 
Table 1. Pathogenesis of IVH. 
2.1.2 Classification – Severity and grading of IVH 
There are two main systems for grading the severity of IVH based on the amount of blood in 
the germinal matrix and lateral ventricles demonstrated by ultrasound or computed 
tomography (CT) scan (Table 2). By US, Volpe grades the IVH in: I, for germinal matrix 
hemorrhage (GMH) with no or minimal IVH, with less than 10% of ventricular volume 
occupying, II for IVH occupying 10%-50% of ventricular area on parasagittal view, III for 
IVH occupying more than 50% of ventricular area on parasagittal view, usually distends 
lateral ventricle. Separate notation: persistent periventricular echodensity (Volpe, 2008). 
Using CT scan Papile grading system is: I for isolated germinal matrix hemorrhage II for 
IVH without ventricular dilatation, III for IVH with ventricular dilatation and IV for IVH 
with parenchymal hemorrhage (Papile et al., 1978). 
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Reference Method Grading Findings 
Papile (1978) 
Computed 
Tomography 
I 
 Isolated germinal matrix  hemorraghe 
(without IVH) 
II IVH without ventricular dilatation 
III IVH with ventricular dilatation 
IV IVH without ventricular dilatation 
Volpe (2008) 
Cranial 
Ultrasonography
I 
Germinal matrix  hemorraghe with no or 
minimal IVH (10% ventricular volume) 
II IVH occupying  10-50% of ventricular area 
III IVH occupying  >50% of ventricular area 
Table 2. Grading IVH by Computed Tomography and Cranial Ultrasonography. 
2.1.3 Clinical presentation and diagnosis 
Clinical presentation varies from a silent syndrome, recognized only when a routine cranial 
US is performed, a mild form with decreased levels of consciousness , hypotonia, abnormal 
eye movements or skew deviation. A catastrophic way with rapid and severe neurological 
deterioration, with seizures, tonic posturing and coma is more rarely (Soul, 2008). 
Whereas any cerebral imaging test is useful, it is almost invariably made by portable cranial 
US. The diagnosis of HIV and PHH is easy and performing fast, quick to make. Premature 
infants are fragile patients carry them to make CT scan or magnetic resonance adds more 
costs, time and risk, and there are hospitals where this exams aren´t available. 
2.1.4 Prevention and treatment 
The most effective strategy to prevent IVH is the prevention of preterm birth. When it 
cannot be avoided, the following prenatal and delivery interventions are associated with a 
reduced risk of IVH. Antenatal corticosteroids, reducing de risk of IVH detected by cranial 
US examination (OR 0.29, CI95% 0.14 to 0.61) (Crowley, 2000). Delayed clamping of the 
umbilical cord more than 30 seconds demonstrated a lower relative risk of IVH versus early 
clamping (RR 0.56, CI95% 0.36 to 0.93) (Rabe et al., 2004). Mothers who are at risk of preterm 
delivery must be transferred to a perinatal center with experience in high risk deliveries and 
care of prematures. Infants who are transferred after delivery are at higher risk for 
developing IVH. Inborn patients compared to those who are transported had a lower 
incidence of IVH (13.2 versus 27.4) and a lower relative distribution of severe IVH (39.2 
versus 44.1 percent) (Mohamed & Aly, 2010). Delivery mode does not appear to affect the 
risk of severe IVH (Riskin et al., 2008) whereas the presence or absence of labor in cesarean 
delivery the data are conflicting. In the neonatal care units the efforts must be put on: 
prompt and appropriate resuscitation of the neonate, avoiding hemodynamic instability, 
hypoxia, hyperoxia, hypercarbia and hypocarbia. All this factors affects the cerebrovascular 
autoregulation; avoid hypotension and hypertension and hemodynamic instability must be 
care avoiding large bolus infusions. Metabolic abnormalities such hyperosmolarity, 
hyperglicemia and hypoglicemia should be prevented. Abnormalities in coagulation should 
be corrected (Bada et al., 1990; Dani et al., 2009; Perry et al., 1990). 
The incidence of IVH is higher in preterm infants with patent ductus arteriosus, they should 
be treating (Jim et al., 2005). Ineffective interventions for prevention IVH includes:  antenatal 
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administration of phenobarbital (Shankaran et al., 1997), antenatal administration of 
magnesium sulfate and vitamin K to the mother has no benefit in prevent IVH (Crowther et 
al., 2010; Volpe, 2008). Postnatal indomethacin and vitamin E are associated a lower risk of 
IVH, but the first increases other risks like gastrointestinal and renal negative effects  and 
the other with an increased risk of sepsis, so it’s use is controversial (Fowlie et al., 2010; 
Brion et al., 2003). 
The treatment doesn´t includes a specific therapy, it is supportive and the main goal is to 
preserve more perfectly cerebral perfusion. Treatment and early detection of complications 
like seizures and PHH, with serial cranial US, will improve the outcome, minimizing further 
brain injury. 
2.1.5 Evolution and prognosis 
IVH is still an important cause of injury in premature infants. The negative impact of IVH 
on neurodevelopmental outcome is due not only to direct consequences of IVH because it 
is also associated to other lesions like PHH or PVL. Long term prognosis for infants with 
IVH varies considerably depending on the severity of IVH, complications or other brain 
lesions such PVL, the most lower birth weight and  gestational age add to others 
significant illness will determinate the outcome. Studies have suggested that preterm 
infants with grade I-II IVH have an increased risk of cerebral palsy and cognitive 
impairment compared who those without (Sherlock et al., 2005; Ancel et al., 2006; Patra et 
al., 2006). Infants with the mayor complications, like PVHI and PHH are at much higher 
risk of permanent neurologic impairments like cerebral palsy than dose with IVH alone 
(de Vries et al., 1999). More than 50% of children born before 32 weeks gestational age 
have school difficulties whether or not they had IVH, although the risk is clearly higher 
among children and adolescents with a story of IVH and lower birth gestational age or 
weight (Bowen et al., 2002; van de Bor & den Ouden, 2004). These cognitive or 
behavioural handicaps are related in part to white matter brain injury. The most effective 
strategy to prevent IVH is the prevention of preterm birth. 
2.2 Periventricular leukomalacia 
PVL refers to damage of cerebral white matter brain injury. The name is based on the 
characteristic distribution and consists of periventricular focal necrosis with subsequent 
cystic formation and more diffuse cerebral white matter injury (Volpe, 2008).  
PVL is the mayor form of brain white matter injury that affects premature infants and it is 
associated with subsequent development of cerebral palsy, intellectual impairment and 
visual disturbances. The great risk for developing PVL is under 32 weeks of gestational age. 
The incidence of PVL varies among centers and in relation with imaging testing realized. 
Based on US, frequency of PVL ranges from 5 to 15% in VLBW infants (Stevenson et al., 
1998). Using MRI, white matter abnormalities are found in 21%, and are associated with 
adverse neurodevelopment outcomes at a corrected age of 2 years. Gray matter 
abnormalities are present in half of infants, and are also significantly associated, but less 
strongly, with cognitive delay motor and cerebral palsy (Woodward et al., 2006). PVL is still 
the principal cause of this neurodevelopmental impairment (Volpe, 2003). 
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2.2.1 Risk factors and pathogenesis 
PVL, lesion found predominantly in preterm infants, can be caused by ischemia or infection. 
The distinctive lesion of PVL found in the immature white matter newborns likely results 
from the interaction of multiple pathogenic factors (Table 3). 
 
Pathogenesis of PVL 
Vascular anatomic 
factors 
Incomplete development of vessels 
Boundary zone around the ventricles 
Circulatory 
factors 
Impaired cerebral vascular autoregulation and 
vasoconstriction 
Cellular 
factors 
Cystic PVL: affects all cell components 
Non cystic PVL:  affects predominantly oligodendrocytes 
Oxidative stress Associated to: maternal/fetal infection 
Cytokines  
Axonal development Particularly susceptible to damage 
Beta amyloid precursor protein identified  in swollen axons 
around PVL (marker of axonal damage) 
Genetics Individual genetic variations 
Table 3. Pathogenesis of PVL. 
To date, the several mayor factors identified are: vascular anatomic factors, pressure-passive 
cerebral circulation, intrinsic vulnerability of cerebral white matter of the premature neonate 
and infection/inflammation. The anatomy of the developing cerebral vasculature renders 
makes the premature infant especially vulnerable to periventricular white matter injury. The 
area near ventricles result in a boundary zone, with incomplete development of vessels that 
penetrates the deep and subcortical white matter, therefore this area is vulnerable to 
reduced flow (Takashima & Tanaka, 1978; Rorke, 1992).The circulatory factors and 
metabolic disturbances can impair autoregulation, resulting in higher risk for developing 
PVL, like HIV. In cystic PVL necrotic changes usually affects all cell components. Diffuse 
non cystic PVL affects predominantly a specific cell lineage, that of oligodendrocytes (Oka et 
al., 1993). Another risk factor is oxidative stress attributed to cerebral ischemia and 
reperfusion and or maternal infection (Khwaja & Volpe, 2008). Expression of inducible nitric 
oxide synthase is increased in brains with PVL (Haynes et al., 2009). Axonal maturation 
studies suggest that axons may be particularly susceptible to damage at time in 
development that coincides with the highest risk of PVL (Haynes et al., 2005). Antenatal risk 
factors like infection increase the risk of premature birth. In a meta-analysis, 
chorioamnionitis was associated with cystic PVL (RR 3.0) and cerebral palsy (RR 1.9) 
(Pidcock et al., 1990). Cytokines produced as a consequence of maternal or fetal infection, 
even the infection is asymptomatic may be associated with PVL, because the white matter is 
especially susceptible to damage mediated by this inflammation factor (Dammann & 
Leviton, 1997). 
2.2.2 Classification – Severity and grading PVL 
Using cranial ultrasound PVL can be classified according to Volpe or de Vries (Volpe, 1990; 
de Vries et al., 1992). Volpe categorizes PVL in mild, with micro cysts smaller than 0.2 mm 
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in specially in parasagittal view, moderate with cysts between 0.2 to 0.5 mm, and severe 
when exists multiple cyst bilaterally bigger than 0.5 mm. According to de Vries, PVL can be 
classified from I to IV grades (Table 4).  
 
Reference Method Grading Findings 
de Vries 
(1992) 
Cranial 
Ultrasonography
I 
transient periventricular echodensities 
persisting for ≥ 7  
II 
transient periventricular echodensity evolving 
into small, lo-calised fronto-parietal cysts 
III 
periventricular echodensities evolving into 
extensive periven-tricular cystic lesions 
IV 
densities extending into the deep white matter 
evolving intoextensive cystic lesions 
Volpe (1990) 
Cranial 
Ultrasonography
Mild micro cysts smaller than 0.2 mm 
Moderate cysts between 0.2 to 0.5 mm 
Severe multiples cysts bilaterally bigger than 0.5 mm 
Table 4. Grading PVL by Cranial Ultrasonography. 
The existence of echogenic lesions without cysts formation for more than 14 days is 
considered as persistent periventricular echogenicity (Larroque et al., 2003). 
For RMI the grading of PVL is more descriptive. Several studies have shown that MRI is 
more sensitive than cranial US for detection of PVL especially for non cystic form of PVL 
(Maalouf et al., 2001; Roelants-van Rijn et al., 2001). 
2.2.3 Diagnosis 
PVL is detected in newborns by brain imaging using US or CT or RMI. Ultrasound is the 
initial standard method because is portable and less expensive. The criteria for US diagnosis 
are not well defined. A standard examination includes coronal and sagital view (Veyrac et 
al., 2006). The US findings evolve on repeated examinations. The cysts appear after one or 
three weeks and disappear after one or three months if they are moderate or severe 
ventriculomegaly may results (Blankenberg et al., 1997). US has limited sensitivity and 
specificity to detect PVL specially if the lesion are less than 0.5 cm. Sonograms may detect 
only one third of lesion identified at autopsy (Papile, 1997). The routine ultrasound 
recommended by the Quality Standard Subcommittee of the America Academy of 
Neurology and the Practice Committee of the Child Neurology Society made the following 
recommendations:  Routine ultrasound screening should be performed on all infants with 
gestational age less than 30 weeks. Screening should be performed at 7 to 14 days of age and 
repeated at 36 to 40 weeks postmenstrual age. This strategy is designed to detect 
unsuspected PVHI, development of PHH or ventriculomegaly. CT scanning is less useful for 
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the diagnosis of PVL in the very preterm infant because it detects fewer lesions than does 
MRI or US (Keeney et al., 1991). Whereas MRI is the most sensible examination the routing 
use of MRI scans for all premature infants has not be recommended although it may be 
useful in some high risk premature infants or older infant or child born prematurely who 
presents with cognitive, motor or sensory impairment (Ment et al., 2002). 
2.2.4 Prevention and treatment 
The strategies to prevent PVL emphasize the maintenance of cerebral perfusion. All 
conditions that impair cerebrovascular autoregulation should avoid by correcting 
abnormalities in blood pressure and blood gases. Antenatal exposure to betamethasone may 
be associated with decrease risk of cystic PVL, more than in infants whose mothers received 
dexamethasone or no received glucocorticoid treatment (Baud et al., 1999). Management of 
PDL after discharge from the hospital is directed at identification of any cognitive, sensory 
or motor impairments, and appropriate therapies for any such impairment. Promising 
studies of neuroprotective strategies to prevent or minimize PVL are being conducted in 
animal models, but human trials of such agents are probably still years away (Oka et al., 
1993; Follett et al., 2004).  
2.2.5 Evolution and prognosis 
Cranial US and brain MRI may yield prognostic information in neonates and children with 
PVL. Infants with more extensive white matter injuries and persistent ventricular 
enlargements are more likely to have severe motor and cognitive deficits. When PVL and 
cystic formation are found in the neonatal period using US, exist a subsequent risk for 
developing cerebral palsy. In a twelve studies review 50% of infants with periventricular 
echolucency developed cerebral palsy compared with 2.6% with infants with normal cranial 
US scans (Holling & Leviton, 1999). Considering the increase on survival rates of extremely 
preterm infants (birth weight less than 1000g it would be reasonable to consider MRI to add 
more prognostic information for such high risk infants. Abnormal white matter a gray 
matter findings on brain MRI at term are predictors of adverse neurodevelopment outcome. 
In VLBW there is an approximately 10% incidence of cerebral palsy and up to 50%incidence 
of school  difficulties largely due to PVL with PVHI being the other cerebral lesion that 
contributes significantly to neurologic disabilities. The incidence of neurologic impairments 
increases with lower gestational age at birth. Cerebral palsy in children born before 36 
weeks gestational age is 20%. Spastic diparesis is the most common form of cerebral palsy in 
children born prematurely because PVL typically affects the periventricular white matter 
closest to the ventricles (Ancel et al., 2006). Despite of these negative numbers thanks to 
therapy and family support some of these children get a social adaptation that increases the 
quality of their lives. 
3. A Chilean experience 
From the years 2001 to 2006, we carried out a prospective cohort study at a tertiary care 
hospital at Valdivia, Chile that includes all inborn neonates with gestational age of 32 weeks 
or less and birth weight of 1500 g or less (Barria & Flandez, 2008). Neonates dead within first 
seven days of age, with major malformation at birth or transferred to another center without 
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ultrasound evaluation were excluded. For this study an experienced pediatric neurologist 
performed serial cranial ultrasound to 164 neonates according the protocol of the Chilean 
Ministry of Health. The images were obtained by using a 7.5-MHz transducer with Medison 
Mysono 201® equipment. The US began within the first week of life, and then at 15 and 30 
days.  
The following epidemiological and clinical variables were obtained from all premature 
infants:  gestational age, birth weight, adequacy of weight to gestational age, gender, Apgar 
score, antenatal use of corticosteroids, type of delivery, rupture of membranes, maternal 
pre-eclampsia and chorioamnionitis.  
Based on the main outcome (IVH: yes/no; PVL: yes/no), variables among groups were 
compared using Fisher exact test for categorical data and the Student t-test or Mann-
Whitney U test for continuous variables. Relative risk (RR) and its 95% confidence interval 
(CI95%) were calculated as univariate estimation of the risk of IVH and PVL. Adjusted odds 
ratios (OR) were estimated using multiple logistic regression with backward stepwise 
incorporation into the initial model of every variable showing a P value ≤ .25 after the 
univariate analysis. The established level of statistical significance was p < .05. Data 
processing and analysis were carried out using Stata 8.1 (Stata Corporation, College Station, 
Texas). 
3.1 Incidence of IVH and PVL, and factors related 
The accumulated incidence of IVH was 18.3% (30/164), distributed in 30% grade I (9/30), 
36.7% grade II, (11/30), 20% grade III (6/30) and 13.3% grade IV (4/30). The percentual 
distribution of IVH by birth weight and gestational age is show in figure 1 and 2, 
respectively.  
 
Fig. 1. Incidence of IVH by birth weight categories. 
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Fig. 2. Incidence of IVH by gestational age categories. 
In the univariate analysis IVH was significantly associated with birth weight, estimating an 
OR of 5.6 (CI95% 1.4 to 21.8) in infants under 750g. In other weight categories there was no 
significant association. According with gestational age, comparing with the group over 30 
weeks, a significantly association was found in infants among 24-26 weeks (OR 5.4, CI95% 
1.72 to 16.7) and among 27-29 weeks (OR 5.4, CI95% 1.72 to 16.7). On the other hand, the 
Apgar at first minute showed a significant reduction in the risk of IVH for each additional 
point in the score (OR 0.82, CI95% 0.70 to 0.95). Other factors analyzed (chorioamnionitis, 
rupture of membranes, pre-eclampsia, etc.) were not significantly associated with IVH. In 
multivariate analysis, only Apgar at one minute was associated independently of the 
outcome of interest. 
Ultrasound assessment allowed the detection of 61 neonates (37.2%) with abnormal white 
matter, 22 with PPVE and 39 with cystic lesion. Thus, the overall incidence for each event 
was 13.4 and 23.8% respectively. PVL was classified as mild in 64.1% (25/39), moderate in 
30.8% (12/39) and severe in 5.1% (2/39). In addition, 23.3% of children with IVH also 
developed PVL (7/30). While PPVE was found in 50% (2/4) at 24 weeks of gestational age, a 
lower incidence remained relatively stable between 25 and 30 weeks, fluctuating between 
14.3 and 16.7%, and declined clearly from week 31. For its part, the c-PVL was found most 
often below 28 weeks, accumulating 66.7% of cases (26/39). Between 24 and 27 weeks, the 
PVL incidence reached at least 50%, and significantly decreased from week 28 (Figure 3). A 
similar pattern occurred in the distribution of c-PVL and PPVE by weight strata, which the 
highest incidence occurred under 1000 g, reaching to below 750 g up to 21.4 and 64.3%, 
respectively. Additionally, the severity of periventricular lesions was higher in most 
premature infants, finding medians of gestational age for PPVE, mild c-PVL and moderate 
to severe c-PVL of 29, 27 and 26.5 weeks, respectively. 
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Fig. 3. Distribution of PPVE and c-PVL by gestational age. 
Birth weight, gestational age, Apgar score and maternal hypertension were significantly 
associated with c-PVL (p<0.05). There were no significant differences in other characteristics 
assessed such as chorioamnionitis, antenatal corticosteroids nor other perinatal factors. In 
the univariate risk estimation, there was an increased risk of c-PVL in extremely low-birth 
weight newborns (<1000g) (RR 5.18, CI95% 2.8 to 9.61) and in infant under 28 weeks of 
gestational age (RR 4.83, CI95% 2.72 to 8.58). A risk reduction effect at border of statistic 
significance was detected for the presence of maternal hypertension (RR 0.48, CI95% 0.23 to 
1.02). There was no effect of Apgar score and other perinatal conditions on the development 
of c-PVL. To PPVE, we found an increased risk with Apgar score ≤ 3 at one minute and 
presence of IVH. The male showed a risk reduction in the limit of statistical significance 
(p=0.058). The extremely low-birth weight and prematurity below 28 weeks showed no 
association with PPVE. 
Our results verify the effect of gestational age (prematurity) and birth weight commented 
previously in this chapter. Highlight of our findings the association found between PVL and 
pre-eclampsia. Consistent with this finding, a study previously has reported that children of 
whose mothers developed preeclampsia with intrauterine growth retardation had a low 
incidence of PVL (0.9%) and showed a significantly lower risk of cystic lesions (OR 0.08, 
CI95% 0,02 to 0.41) (Baud et al., 2000). In this sense, other study showed that none of the 
infants with a history of preeclampsia had c-PVL (Murata et al., 2005). However, other 
researchers found that this effect has been limited until 32 weeks, observing, on the 
contrary, an increased risk in children between 33 and 35 weeks of gestational age (Resch et 
al., 2000). Consequently, although the evidence is unclear, there is pathophysiologic support 
for considering hypertension in pregnancy as a protective factor on the incidence of c-PVL, 
based on self-regulatory mechanisms of the fetoplacental circulation developed in response 
to fluctuations of vascular tone. This would allow deal adequately potential hypoxic-
ischemic episodes in the fetal brain. In this function, activation of the renin-angiotensin 
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system in the fetoplacental unit caused by pre-eclampsia, would have a principal action (Ito 
et al., 2002). Likewise, hypertension and growth restriction can accelerate neurological 
maturity (Hadi, 1984), suggesting that early maturation may reduce brain disorders. It is 
also likely, however, that there are intermediate factors in this causal chain that must be 
clarified. 
3.2 Follow up at four years 
From 153 children potentially eligible born between September 2001 and June 2005 were 
included 81 preterm infants <32 weeks and/or VLBW with neurological evaluation at the 
fourth year of life (52.9%). Of the remainder, in 12 cases there was no record and in 60 there 
was no neurological control at this age. We calculated the incidence of neurological 
disorders and assessed association for different variables using t-test and Fisher exact test. 
Risks were calculated for overall and specific neurological areas for different variables, by 
estimating crude and adjusted odds ratio using multiple logistic regression. 
At discharge from the hospital, 17.5% of the infants developed IVH and 23.4% cystic PVL of 
varying degrees. At 4 years, 30.9% of patients were diagnosed with some degree of 
alteration in any of the evaluated areas. Eighteen children (22.2%) showed cognitive 
impairment: 61% mild, 33.3% moderate and 5.5% severe. In motor area, 16 children showed 
affection, highlighting 37.5% (6/16) of spastic diplegia and 43.7% (7/16) hemiparesis. Six 
children (7.4%) showed sensory (visual, auditory or both) and social deficits.  
In multivariate analysis, the gestational age was significantly associated with motor disorder 
estimating an adjusted OR 0.57 for each additional week (CI95% 0.40 to 0.81). The history of 
IVH also showed a significant association estimating an OR 4.3(CI95% 1.1 to 17.7). Similarly, 
for cognitive impairment, was estimated a lower risk with higher gestational age (OR 0.64, 
(CI95% 0.42 to 0.95). 
4. Conclusion 
Gestational age is an important predictor of neurologic outcomes and therefore the 
systematic monitoring of premature infants allows the diagnosis need to target intervention 
and/or rehabilitation for improving the quality of life of the child and family. Since 
prematures improve surviving, decreasing the adverse outcomes taking the best strategies 
to prevent brain injury is must necessary. Preventing the premature birth is the main goal. 
When it isn´t possible, knowing the pathofisiology of the brain lesions and it´s risk factors 
can minimizes the final results in terms of neurodevelopment. Strategies in early 
intervention for lower motor handicaps, specially in whose have cranial US altered is 
needed. Their periodic neurological evaluation for finding behavioural and cognitive 
impairments is needed for giving them the best expectations in their quality of live. 
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